COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I FLVFLV REGNR2 LY-CoVLY RemdesivirRMD
Ivermectin study #1 of 63
5/2 Early treatment study
Chang, G., Research Gate, doi:10.13140/RG.2.2.34689.48482/7 (Preprint)
Inclusión de la ivermectina en la primera línea de acción terapéutica para COVID-19
Source   PDF   Share   Tweet
Peru observational case study of 7 patients treated with ivermectin, showing improvement and resolution of fever within 48 hours, and 100% recovery.

Chang et al., 5/2/2020, preprint, 1 author.
Details of all 63 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit